Basina, B.O. and Kondrateva, G.V. (2016) Could really systemic inflammatory markers be predictors of COPD Progression. The Pharma Innovation Journal, № 5 (5). pp. 91-93. ISSN 2349-8242 (print), 2277- 7695 (online)
![[img]](http://repo.dma.dp.ua/style/images/fileicons/text.png) |
Text
5-5-4-553 индия статья 2016 год.pdf Download (227kB) |
Abstract
Inflammatory biomarkers are considered by modern researchers as one of the best markers of effectiveness of inhaled corticosteroids (ICS) at patients with COPD, but there are a few studies about their prediction opportunity for COPD progression. The study is devoted to study of the diagnostic value of some markers of systemic inflammation (CRP, fibrinogen, MMP-2 and -9, hyaluronic acid (HA) at patients with COPD, there role as predictors of COPD progression. It was determined that determination of dynamic levels of such marker of systemic inflammation as MMP-2, CRP, HA can be used as parameters for further evaluation of the clinical stability of patients during their long-term follow-up. Significant decreasing of inflammatory markers shows the adequacy of anti-inflammatory therapy of patients with COPD regardless of changes in lung function dynamic disorders.
| Item Type: | Article |
|---|---|
| Uncontrolled Keywords: | chronic obstructive pulmonary disease, systemic inflammation, predictors, biomarkers. |
| Subjects: | Internal Medicine |
| Divisions: | Departments > Department of Internal Medicine 1 (formerly - Faculty Therapy and Endocrinology) |
| Depositing User: | Анастасия Жигар |
| Date Deposited: | 08 Jul 2016 07:07 |
| Last Modified: | 26 Jun 2017 07:19 |
| URI: | http://repo.dma.dp.ua/id/eprint/743 |
Actions (login required)
 |
View Item |
